A Periadrenal Gland Ewing Sarcoma With Extensive Posttreatment Ganglioneuroblastoma-Like Morphology in an Adult Patient.

Int J Surg PatholMay 15, 2026 (epub)

Xi Wang, William Laskin, Hao Wu

✦ AI-curated · Sources linked

Case in brief

A 33-year-old man presented with a retroperitoneal periadrenal mass, exhibiting features of Ewing sarcoma. Initial biopsy revealed small round cells with Homer-Wright rosettes and positive CD99 expression. Following neoadjuvant chemotherapy, resection showed a biphasic tumor with ganglioneuroblastoma-like morphology alongside a minor round cell sarcoma component. EWSR1 rearrangement was confirmed in both biopsy and resection specimens.

What made this case unusual

The case highlights posttreatment cytodifferentiation resembling ganglioneuroblastoma in an adult with Ewing sarcoma, a phenomenon rarely documented in this demographic.

Diagnostic / clinical pearl

Clinicians should be aware that Ewing sarcoma can undergo cytodifferentiation post-chemotherapy, potentially mimicking neuroblastoma, which may complicate diagnosis.

Why it matters

Understanding this morphological change is crucial for accurate diagnosis and management, particularly in adult patients where such presentations are uncommon.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.